Direktlink:
Contents; Accesskey: 2 | Hauptnavigation; Accesskey: 3 | Servicenavigation; Accesskey: 4
Layoutbild
 

Factfile

Flu vaccines: A revolution behind the blinds

22.01.2007
Chicken eggs – their services to vaccine production will soon end.
Source: Pixelquelle.de

To date, avian flu remains an animal virus, having only taken human lives in a few rare cases. But in the spring of 2006, the deadly virus was first discovered in wild living swans in Germany, raising fears of an increased danger for humans. Viruses are veritable artists of adaptation, and experts no longer consider an avian flu pandemic to be an unlikely scenario. With this thought in mind, pharmaceutical companies are working feverishly on possible vaccines, hoping to have a weapon at hand for worst-case scenarios and, behind the lab window blinds, a small revolution is taking place. For the first time, the production of flu vaccines, unchanged in over 50 years, is facing competition from cell-based approaches. Approval for the first vaccine produced in this way is now awaited.

The protection: sophisticated preparation of the body's own defences

Day-to-day, the human body is equipped with an intelligent defence system, which can quickly identify foreign aggressors such as bacteria or viruses. This defence, the immune system, is engaged in a constant battle with harmful intruders, after which it stores away information about their outward appearance, much like a ‘wanted’ poster. This process, which helps the body to identify the pathogens should they reappear, takes place over several stages. First, the immune system recognizes foreign bodies using specific three-dimensional surface characteristics, known as antigens. Then, the body constructs complex protein molecules, the anti-bodies, which tackle and ideally paralyze the intruders. So that the immune system does not have to repeatedly fight the same pathogens from scratch, these anti-bodies are stored in so-called memory cells, like an archive of identikit photos. If an infection occurs again, the immune system will fall back on this system and recognize the pathogen immediately. In such a way, the immune system is able to react extremely quickly and destroy any harmful invaders, before the outbreak of illness.

Vaccination – exploiting a natural strategy

Vaccination uses exactly the same natural strategy to deliberately prepare the body’s own defences against a pathogenic attack. The word ‘vaccine’ originates from the Latin "vaccina", meaning "coming from cows". This designation stems from the discovery of a natural vaccination: Farm servants who had been earlier infected with the harmless cow smallpox were immune to the deadly human smallpox.

Meanwhile today there is an entirely different approach, in which vaccines are made up of viruses which are no longer infectious. Ultimately, vaccinations are not intended to make people ill, but to activate their immune system in such a way that it is nevertheless powerful enough to prevent an illness in the case of a viral attack. The development of vaccines against flu goes back many decades. After the flu virus was discovered for the first time in 1933, research establishments, above all those of the US military, began working on a vaccine. However, the first generation of flu vaccines in the early 50's consisted of crudely cleansed viruses, which resulted in a great deal of other illnesses and side-effects. In contrast, modern vaccines are highly optimized molecules, derived from dead, non-infectious viruses or small parts of viruses.


Flu vaccinationLightbox-Link
Flu vaccination.
Source: Novartis Behring

Flu: Every year a fresh vaccination recommended

Due to flu viruses’ transforming abilities, through ‘shifts and drifts’, vaccination against flu has to take place at least once a year, which is the only way to remain effectively immune to the viruses. Every year, for the new vaccine, the World Health Organization (WHO) selects the three virus strains which have caused the most cases of flu in the previous flu season. The selection is made using a complex system of stations, which are distributed across the globe. 112 centres in 83 countries annually announce their findings of the latest variants. In Germany, there are two national influenza centres working together with the WHO: The Robert Koch Institute in Berlin and the National Reference Centre for influenza Monitoring in Hanover. When the information has been gathered, a new vaccine is manufactured with a fresh composition for every new flu season. However, selecting these virus strains involves no small amount of prophecy - nobody can be completely sure exactly which strains will be the dominant agent behind the next wave of flu. The end result of this is that protection from flu by vaccination is never 100% certain.

 
top

Context

Pharmaceutical companies are working feverishly on possible flu vaccines, hoping to have a weapon at hand for worst-case pandemic scenarios. To date, flu vaccines  are produced using the same fundamental technique as the first industrially manufactured vaccines, unchanged over 50 years: in live chicken eggs. However, there are changes afoot in the industry: The pharma concern Novartis has produced a flu vaccine using a cell culture and has now applied for European approval for its new product.

In contrast with the use of eggs, the production of a cell-based vaccine takes only 16 weeks. What is more, the capacity can be adapted more easily to the actual demand.

Politicians have recognised the danger of a pandemic and in March 2006, the German government has decided to support infection research  backed by 60 million euros of public funding.